The Importance of Regulatory Strategy
Getting a new drug to the patient involves numerous stakeholders that are part of a multi-faceted regulatory framework. This framework has evolved over time and proceeds from drug discovery to development to regulatory evaluation.
Whitepaper Jun 13, 2022
Insights Into Working With Rare Diseases
We’ve asked some of our experts to share insights on the challenges posed by rare diseases in healthcare, particularly in the wake of the ongoing COVID-19 pandemic. Each has given their own take based on their experience of working in the rare disease space, based on the impact on payers, pharmaceutical companies and, most importantly, patients.
View Mar 1, 2022